Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICATIBANT vs ICOSAPENT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ICATIBANT vs ICOSAPENT: Safety Overview

Metric ICATIBANT ICOSAPENT
Total FAERS Reports 5,363 123
Deaths Reported 234 4
Death Rate 4.4% 3.3%
Hospitalizations 2,451 87
Average Patient Age 46.3 yrs 50.0 yrs
% Female Patients 75.0% 50.4%
FDA Approval Date Aug 14, 2023 N/A
Manufacturer Alembic Pharmaceuticals Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A